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ABSTRACT
Canine babesiosis is a multisystemic protozoan disease, considered as sepsis with a wide range of clinical 
signs, which can result in various outcomes, from mild to fatal. In veterinary medicine there are still no 
 specifi c biomarkers for sepsis, therefore the aim of this study was to investigate markers widely used in human 
medicine, but poorly in veterinary medicine and never in canine babesiosis. Ninety-seven dogs were included 
in this study, among which 72 were diagnosed for babesiosis and 25 were healthy and used as the control 
group. Concentrations of procalcitonin (PCT) and the amino-terminal portion of C-type pronatriuretic peptide 
(NT-pCNP) were determined for each dog. There was a signifi cant difference in PCT concentrations between 
the healthy and the babesiosis group before and after the antibabesial treatment, but there were no signifi cant 
differences between the dogs that survived and the dogs that died. In contrast, there was no signifi cant difference 
in NT-pCNP concentrations between the healthy and babesiosis groups before and after the antibabesial 
treatment, but there were signifi cant differences between the dogs that survived and the dogs that died. It may 
be concluded that as in human medicine, PCT is most probably a good marker for both detection and grading 
of SIRS complications developed only in bacterial induced systemic infections, whereas NT-pCNP can be 
considered a good prognostic pro-infl ammatory marker of outcome in canine babesiosis.
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Introduction
Canine babesiosis is a multisystemic protozoan and potentially fatal disease. Dogs 
can be infected with a wide range of Babesia species (BECK i sur., 2009). The vast majority 
of canine babesiosis in Croatia is caused by B. canis (BECK et al., 2009; BRKLJAČIĆ et al., 
2010) and it has a wide range of clinical signs, which can result in various outcomes, from 
mild to fatal (MATIJATKO et al., 2010; MATIJATKO et al., 2012).
The differences in clinical manifestations of babesiosis appear to be the result of the 
interplay of the parasite-host interactions. A hypothesis that may explain all the different 
manifestations of the disease is that systemic infl ammatory response syndrome (SIRS) 
and subsequent multiple organ dysfunction syndrome (MODS) provide the underlying 
pathophysiologic mechanism within which apparently unrelated aspects of babesiosis 
form a predictable pattern (SCHETTERS et al., 2009). The host response to the infection is a 
complex process and the pro-infl ammatory state of the acute phase response also initiates 
anti-infl ammatory mediators. The extent of the pro- and anti-infl ammatory events should 
be balanced and proportional to the insult (ABBAS et al., 2000).
In veterinary medicine there are still no specifi c biomarkers for sepsis and therefore 
many studies are in progress with the goal of fi nding a reliable diagnostic and prognostic 
marker of sepsis in various animal species (MATIJATKO et al., 2007; DeCLUE et al., 2011; 
BRKLJAČIĆ, 2012). In canine babesiosis various biomarkers have already been studied, 
namely acute phase proteins in cases of canine babesiosis caused by B. canis (MATIJATKO 
et al., 2007) and B. rossi (KOSTER et al., 2009). More recently, cytokines were investigated 
as markers in canine babesiosis (MAYER, 2012).
Procalcitonin (PCT) is a biochemical peptide precursor of hormone calcitonin, 
and is considered to be the best prognostic marker used to monitor the clinical course 
and progression of various infl ammatory states in humans, especially in cases of SIRS, 
sepsis and MODS (MEISNER et al., 1999). High concentrations of PCT were detected in 
patients with malaria, a disease with extremely similar pathogenesis to canine babesiosis. 
Furthermore, a correlation between concentrations of PCT and the severity of the disease 
has also been noted (DAVIS et al., 1994; AL-NAWAS and SHAH, 1997; HESSELINK, 2009). 
PCT is an excellent marker for distinguishing SIRS from sepsis and it has several 
advantages compared to human C-reactive protein (CRP). Most important of all, PCT 
has wide range reactivity, which results in a signifi cant rise in its plasma concentrations 
in severe forms of MODS, as well as in serious systemic infl ammations (MEISNER et al., 
1999). Therefore, in human medicine PCT is a better and much more precise marker than 
CRP, whose concentrations usually reach maximum values even in mild or moderate 
grades of infl ammation (MEISNER et al., 1999). 
C-type natriuretic peptide (CNP) is expressed primarily by the vascular endothelium 
and macrophages in response to several stimuli, such as tumour necrosis factor (TNF), 
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interleukin-1β (IL-1β), or transforming growth factor-β (TGF-β), which are known to 
play a role in the pathogenesis of sepsis. Furthermore, it has been proven that microbial 
products directly stimulate production of CNP (SUGA et al., 1993). Therefore, CNP is an 
interesting biomarker for sepsis, but with questionable clinical use because of its poor 
stability in peripheral blood (DEL RY et al., 2011).
Recent identifi cation of the amino-terminal (NT) portion of proCNP (pCNP), together 
with assay development, compensates for all the missing features of CNP, and because 
of its practical potential it represents a new method for evaluating CNP production. NT-
pCNP is a reliable marker of CNP biosynthesis, because they are both produced as well 
as secreted in equimolar amounts (DEL RY et al., 2011). Compared with CNP, NT-pCNP 
is a larger molecule with a longer half-life in circulation and does not correlate with 
other natriuretic peptides, so this all together makes it exploitative for clinical purposes 
(PRICKET et al., 2001).
The majority of studied biomarkers appeared to be good in differentiating dogs 
infected with Babesia sp. from healthy dogs, but they were unable to predict the outcome 
of the disease. To our knowledge, both PCT and NT-pCNP have not yet been investigated 
in canine babesiosis. Therefore, the aim of this study was to investigate these two markers 
(PCT and NT-pCNP), widely used in human medicine, but sporadically in veterinary 
medicine, and never in canine babesiosis.
Materials and methods
Ninety-seven dogs were included in this study. Among those, seventy-two had 
babesiosis, diagnosed at the Clinic for Internal Diseases, Faculty of Veterinary Medicine 
University of Zagreb. The remaining twenty-fi ve dogs were admitted to the same Clinic 
either for a routine yearly examination (15 of them) or for antibabesial drug administration 
(10 of them). In ten of them imidocarb dipropionate (Imizol®, Schering-Plough, Essex 
Animal Health, Friesoythe, Germany) was administrated for prophylactic purposes (6.6 
mg/kg subcutaneously) at the owner’s request. Since babesiosis is a very frequent disease 
in Croatia, despite the numerous tick preventative treatments, many dogs are still being 
infected with babesiosis, so their owners sometimes request this kind of prophylaxis. 
Healthy dogs (with clinical and laboratory fi ndings within reference ranges) admitted 
for a routine yearly check-up, together with dogs preventively treated with Imizol® (also 
with clinical and laboratory fi ndings in reference ranges), were included in this study as a 
healthy control group, in order to investigate whether the antibabesial drug has an impact 
on investigated parameters.
After the fi rst physical examination, samples of blood were taken from v. cephalica 
antebrachii in EDTA-containing tubes, as well as in tubes without any additive.
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Dogs with babesiosis and healthy dogs treated with antibabesial drug were sampled 
twice, upon admission and 24 hours after antibabesial treatment. Fifteen healthy dogs who 
were not treated with Imizol® were sampled only once. Haematology and biochemistry 
profi les, as well as the concentrations of PCT and NT-pCNP, were determined for each 
dog.
Babesiosis was confi rmed by demonstration of the parasite in blood smears 
stained with May-Grünwald/Giemsa solutions. All the dogs suffering from babesiosis 
were treated with 6.6 mg/kg of Imizol® just after establishing the diagnosis, together 
with supportive therapy in those who needed it (crystalloid and colloid fl uid therapy, 
transfusion, antimicrobial drugs etc.).
DNA was extracted from 200 μL of EDTA-treated blood using the DNeasy® Blood 
and Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions 
in an automatic system for DNA isolation, QIACube® (Qiagen, Hilden, Germany). 
Amplifi cation of a fragment (~560 bp) of the 18s rRNA gene was obtained using two 
pairs of primers according to HERWALDT et al. (2003) in nested PCR.
Amplifi cation of longer fragment (1715 bp) was obtained with the forward primer 
CRYPTO F 5’-AACCTGGTTGATCCTGCCAGTAGTCAT-3’ and the reverse primer 
CRYPTO G 5’-GAATGATCCTTCCGCAGGTTCACCTAC-3’. Amplifi ed DNA was 
subjected to capillary electrophoresis by QIAExcel (Qiagen, Hilden, Germany) and 
viewed under UV light. PCR products were purifi ed using a ExoSAP-IT® CLEAN UP 
(USB, USA) according to the manufacturer’s instructions and fully sequenced using an 
ABI PRISM® BigDyeTM Terminator system and GeneAmp® PCR 2400 (PE Biosystems, 
USA) with forward primer BAB F 5’- CCCTTCATCGGTGGTAACTT-3’ and reverse 
primer BAB R 5’-GTGGCCACCACTCCCGTGCC-3’. Sequences were assembled 
using Lasergene® software (DNASTAR, Madison WI, USA) together with the pertaining 
SeqManTM and EditSeqTM software. Obtained sequences were compared within the 
Gen Bank procurable sequences in order to identify the Babesia species.
Haematology profi le was performed using a Horiba ABX Hematology Analyser 
(Diagnostics, Montpellier, France), while biochemistry profi le was performed using 
an Olympus AU 600 Analyser with original reagents (Olympus Diagnostica GMBH, 
Hamburg, Germany).
Concentrations of PCT was obtained by the ELISA method using Canine 
Procalcitonin, PCT ELISA Kit (Wuhan EIAab Science Co. Ltd., China) and the automatic 
machine ChemWell 2910 (Awareness Technology Inc., USA) by measuring absorbance 
after adding stop-solution at 450 nm.
Concentrations of NT-pCNP were obtained by the ELISA method using an NT-
proCNP kit (Biomedica, Austria) and automatic machine ChemWell 2910 (Awareness 
Technology Inc., USA) by measuring absorbencies after adding stop-solution at 450 
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nm. The NT-proCNP assay utilises a highly purifi ed polyclonal sheep antibody directed 
against aminoacids 1-19 and 30-50 of human NT-proCNP (96% homologous with canine 
proCNP (http://www.ncbi.nlm.nih.gov/genome/guide/dog; http://blast.ncbi.nlm.nih.gov/
Blast.cgi). This kit has already been used in detecting NT-proCNP in dogs (DECLUE et 
al., 2011). 
Statistical analysis. Descriptive statistics was performed according to the usual 
statistical methods and normality was tested by means of the Kolmogorov-Smirnov test. 
No distributions were normal so we used the Sign test to test differences between the 
same animals on two consequent days and the Kruskal-Wallis test to test differences 
within the same variable but between different groups, according to the severity of 
the disease (healthy, babesiosis survivors and babesiosis non-survivors). The level 
of signifi cance was set at P<0.05. Correlations between investigated parameters were 
tested by Spearman rank order (level of signifi cance was set at P<0.05). All statistical 
analyses were performed using the statistical software program Statistica (Statistica 8 for 
Windows, StatSoft Inc.).
Results
Dogs presented to the Clinic for Internal Diseases of the Faculty of Veterinary 
Medicine, University of Zagreb, between January 2009 and January 2011 were included 
in this study and babesiosis was diagnosed in seventy-two dogs during the study period. 
Among them there were 52 males and 20 females, aged from 6 months to 10 years and of 
different breeds including mixed breed dogs (n = 26). 
Microscopic evaluation of blood smears demonstrated the presence of large (3-5μm), 
pyriform parasites, namely B. canis in erythrocytes of all 72 sick dogs. Sequence analysis 
confi rmed the presence of B. canis in all 72 samples tested. 
Since there were no signifi cant statistical differences between the two subgroups of 
healthy dogs (namely those who were pretreated with an antibabesial drug and those who 
were not), they were joined and observed as one control group (n = 25). 
On the day of admission, all the dogs with babesiosis included in this study presented 
with one or more of the following clinical signs: depression (70/72), anorexia (71/72), 
pale mucous membranes (44/72), fever (40/72), splenomegaly (35/72) and dark coloured 
urine (29/72). Among the dogs studied, 4 dogs died and 68 dogs survived babesiosis, so 
the mortality rate was 5.8%. 
On the day of admission, white blood cell count (WBC), platelet count (PLT) and 
haematocrit (HCT) were signifi cantly lower (P<0.01) in dogs with babesiosis compared 
to the control group. The mean white blood cell count was signifi cantly lower before 
antibabesial treatment and signifi cantly higher after antibabesial treatment in the 
babesiosis group, compared to the group of healthy dogs. The mean platelet count showed 
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an upward trend from the fi rst day to the second day. There were no signifi cant differences 
in the studied hematological parameters between the dogs with babesiosis that survived 
compared to the dogs that died. 
Total protein, albumin and blood glucose concentrations and alkaline phosphatase 
activity were signifi cantly different (P<0.05) in dogs with babesiosis in comparison to the 
healthy group (Table 1).
Blood urea nitrogen, creatinine and total bilirubin concentrations and alkaline 
phosphatase activity were signifi cantly different (P<0.05) in dogs that died versus those 
that survived babesiosis (Table 1).
Fig. 1. NT-pCNP concentration (pmol/L) in control group, canine babesiosis survivors group and 
canine babesiosis non-survivors group before antibabesial treatment (NTpCNP0). *Indicates a 
signifi cant difference (P<0.05) by the Kruskal-Wallis test. The plots show the median (square 
within box), 25th and 75th percentiles (box), and range (whiskers).
Table 2. Correlations of investigated parameters with the outcome of babesiosis. (Spearman Rank 
Order - result was considered as signifi cant for P<0.05).
Investigated parameter Negative outcome
NT-pCNP before antibabesial treatment P<0.01; R = 0.991
NT-pCNP after antibabesial treatment P<0.01; R = 0.888
PCT before antibabesial treatment P<0.01; R = -0.06
PCT after antibabesial treatment P<0.01; R = -0.05
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Fig. 2. NT-pCNP concentration (pmol/L) in control group, canine babesiosis survivors group 
and canine babesiosis non-survivors group after antibabesial treatment (NTpCNP1). *Indicates 
a signifi cant difference (P<0,05) by the Kruskal-Wallis test. The plots show the median (square 
within box), 25th and 75th percentiles (box), and range (whiskers).
Fig. 3. PCT concentration (pg/mL) in control group, canine babesiosis survivors group and canine 
babesiosis non-survivors group before antibabesial treatment (PTC0). *Indicates a signifi cant 
difference (P<0,05) by the Kruskal-Wallis test. The plots show the median (square within box), 
25th and 75th percentiles (box), and range (whiskers).
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Fig. 4. PCT concentration (pg/mL) in control group, canine babesiosis survivor group and canine 
babesiosis non-survivors group after antibabesial treatment. * Indicates a signifi cant difference 
(P<0,05) by the Kruskal-Wallis test. The plots show the median (square within box), 25th and 75th 
percentiles (box), and range (whiskers).
There was no signifi cant difference in NT-pCNP concentrations between the 
healthy and babesiosis groups (both survivors and non-survivors) before and after the 
antibabesial treatment. However, there were signifi cant differences before as well as after 
the antibabesial treatment in NT-pCNP concentrations between the dogs that survived and 
the dogs that died (Fig. 1 and Fig. 2).
In contrast, there was a signifi cant difference in PCT concentrations between the 
healthy and the babesiosis groups (both survivors and non-survivors) before and after the 
antibabesial treatment, but there were no signifi cant differences before, as well as after 
the antibabesial treatment in PCT concentrations between the dogs that survived and the 
dogs that died (Fig. 3 and Fig. 4).
A statistically signifi cant positive correlation was established between both NT-pCNP 
and PCT concentrations and negative outcome before and after antibabesial treatment 
(Table 2). There was no statistically signifi cant correlation between NTpCNP and PCT 
before antibabesial treatment (R = -0.09, P>0.05) or after antibabesial treatment (R = 
-0.077, P>0.05) in both groups of babesiosis (survivors and non-survivors).
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Discussion
Canine babesiosis is an economically important and potentially life-threatening 
disease which has worldwide distribution, with numerous cases reported throughout the 
United States, South Africa, Asia and Europe (ANDERSON et al., 1980; LOBETTI, 1998; 
ZAHLER et al., 2000; CACCIO et al., 2002), and which involves several pathophysiological 
mechanisms that are still not completely understood (JACOBSON and CLARK, 1994; 
BOOZER and MACINTIRE, 2003). Until now, Babesia canis, B. vogeli, Theileria annae, 
Theileria equi, B. cabali and B. gibsoni have been isolated from dogs in Croatia, with B. 
canis being the most frequent cause of canine babesiosis in Croatia (BECK et al., 2009). 
This study included a large number of dogs of more than 30 breeds. Based on hospital 
records, the breed distribution roughly represents the popularity of breeds in Croatia. 
Also, in this study there were 52 males and 20 females. This ratio between male and 
female dogs with babesiosis could be explained by the predominance of male dogs in 
Croatia, together with the fact that males are usually prone to wandering which increases 
their exposure to ticks.
Considering the fact that sepsis is defi ned as SIRS that can be attributed to a confi rmed 
bacterial, viral, fungal or protozoal infection, canine babesiosis, like human Plasmodium 
falciparum malaria can be classifi ed as protozoal sepsis (BONE et al., 1992; JACOBSON 
et al. 2002; MATIJATKO et al., 2009). SIRS that precedes MODS is caused by excessive 
release of infl ammatory mediators (LOBETTI, 2000). 
It is important to be aware that SIRS is an extremely complex phenomenon, and that 
numerous pro-infl ammatory and anti-infl ammatory mediators play an important role in its 
development. Furthermore, their mutual balance is of utmost importance for the outcome 
of the infl ammation, so dysbalance of these mediators results in development of multiple 
complications, which cannot be viewed as individual occurrences caused by a single 
event. Thus, development of complications is initiated by numerous factors, so when a 
complication occurs it is likely that development of several more will follow, which will 
result in MODS. Since MODS signifi cantly infl uences the outcome of canine babesiosis 
(MATIJATKO et al., 2007; MATIJATKO et al. 2009), early recognition of its development, 
and monitoring its course are crucial.
Since there are many different forms of all kinds of severe diseases that are clinically 
indistinguishable, high-quality biomarkers for diagnosis and prognosis of canine sepsis 
are of utmost importance and still searched for (DeCLUE et al., 2011).
Erythrocyte sedimentation rate (ESR) has been routinely used as a non-specifi c 
marker in the diagnosis of infections in human medicine (SOX and LIANG, 1986; GABAY 
and KUSHNER, 1999) since an accelerated ESR is caused by an increased concentration 
of acute phase proteins, especially fi brinogen (RUHENSTROTH-BAUER et al., 1990). 
However, the results obtained with the ESR test should be interpreted cautiously because 
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a reduced haematocrit can increase the ESR. Therefore, it cannot be considered to be an 
optimal laboratory test for monitoring a haemolytic disease such as canine babesiosis 
(MATIJATKO et al., 2007). Regarding other haematological tests, the WBC was not 
demonstrated to be adequate in detecting and monitoring canine babesiosis since it had very 
low sensitivity (MATIJATKO et al., 2007). Canine babesiosis caused by B. canis produces 
an acute phase response with increased concentrations of acute phase proteins. CRP 
and SAA demonstrated higher sensitivity in detecting canine babesiosis than traditional 
infl ammatory markers, such as WBC and ESR. Sequential measurement of C-reactive 
protein and serum amyloid A concentrations proved valuable in monitoring response 
to antibabesial treatment in uncomplicated canine babesiosis (MATIJATKO et al., 2007). 
However, CRP concentrations showed no signifi cant difference between uncomplicated 
and complicated babesiosis and therefore it did not prove useful in predicting the outcome 
(KOSTER et al., 2009). 
NT-pCNP is considered a useful sepsis biomarker in human medicine (PRICKET et 
al., 2001). It is presumed that NT-pCNP could be important in innate immune response 
to infection because of its ability to exhibit antimicrobial activity by inhibiting microbial 
growth, as well as modifying the pathogenicity of microorganisms (VERON et al., 2008). 
KOCH et al. (2010) investigated the NT-pCNP concentration values in severely ill, both 
septic and non-septic people, as well as in healthy ones, and noted a large difference 
between these groups. They also concluded that a decrease in NT-pCNP concentration is 
usually correlated to a good outcome. 
A clinical study conducted on dogs that developed only SIRS and dogs that developed 
sepsis as a sequel to SIRS, showed that measurement of NT-pCNP concentrations 
could have great potential in differentiating canine SIRS from sepsis, except in septic 
peritonitis (DeCLUE et al., 2011). The authors of the aforementioned study did not fi nd 
NT-pCNP concentrations as a good outcome-predicting marker, since there were no 
signifi cant differences in NT-pCNP concentrations of dogs that survived compared to 
dogs that died. In contrast, in our study, the highest concentrations of NT-pCNP were 
obtained in non-survivors, and were statistically signifi cantly higher than in survivors, 
but we did not observed signifi cant differences in NT-pCNP concentrations between the 
dogs with babesiosis and healthy controls. Considering these results, measuring of NT-
pCNP concentrations should be thoroughly investigated because high concentrations of 
NT-pCNP measured in dogs with babesiosis could be in close positive correlation with 
mortality.
PCT is considered to be an excellent marker of sepsis in human medicine (DAVIS 
et al., 1994; AL-NAWAS and SHAH 1997; MEISNER, 2000). It is important to note that 
concentrations of PCT in less severe forms of disease are not so high, but they are 
higher than in healthy ones. Only a few studies of PCT concentrations in dogs have been 
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published so far. To our knowledge, there have been only two studies in which canine PCT 
concentrations were obtained by chemiluminescence assay using LUMItest PCT reagens 
(BRAHMS Diagnostica GmbH, Hennigsdorf/Berlin, Germany). In one of these studies, it 
was noticed that there was a signifi cant difference in PCT concentrations between the dogs 
that developed SIRS and those that did not, but still there was no difference between septic 
and non-septic dogs (GIUNTI et al., 2006). In another study, by MATIJATKO (2003) there 
were no signifi cant differences between PCT concentrations in healthy dogs versus dogs 
with babesiosis. In our study there were no signifi cant differences in PCT concentrations 
between dogs who survived babesiosis and dogs that died due to babesiosis, but there was 
a statistically signifi cant difference between PCT concentrations in healthy dogs and dogs 
with babesiosis (both survivors and non-survivors). 
Regarding these results PCT should be considered to be a useful marker in 
differentiating healthy dogs from dogs with babesiosis, but should not be considered 
as a good prognostic marker of the outcome of canine babesiosis. On the basis of the 
aforementioned fi ndings, it can be concluded that PCT is a good marker for differentiation 
of healthy dogs and dogs that have babesiosis, but it has not proven to be a good prognostic 
marker and as such cannot be used to predict the outcome of canine babesiosis. 
Considering correlations between investigated parameters and the outcome (Table 
1) it can be concluded that NT-pCNP is inverse to PCT, and is a good prognostic 
proinfl ammatory marker of outcome in canine babesiosis.
_______
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SAŽETAK
Babezioza pasa je multisistemska protozojska sepsa sa širokim rasponom kliničkih znakova od blagih do 
onih sa smrtnim ishodom. U veterinarskoj medicini još uvijek nisu pronađeni specifi čni biomarkeri sepse pa je 
stoga cilj ovog istraživanja bio ispitati markere koji se obilno koriste u humanoj medicini, ali su slabo istraženi 
u veterinarskoj medicini, a nikada kod babezioze pasa. U ovo istraživanje bilo je uključeno 97 pasa od kojih 
je u 72 psa dijagnosticirana babezioza dok je preostalih 25 bilo zdravo i korišteno kao kontrolna skupina. Kod 
svakog psa određene su koncentracije prokalcitonina (PCT) i aminoterminalnog dijela C-tip pronatrijuretičkog 
peptida (NT-pCNP). Zabilježena je statistički značajna razlika u koncentraciji PCT-a između zdravih pasa i 
bolesnih pasa prije i nakon antibabezijske terapije, no nije bilo statistički značajne razlike između preživjelih 
i uginulih. Naprotiv, nije zabilježena statistički značajna razlika u koncentraciji NT-pCNP-a između zdravih i 
bolesnih pasa, ali je nađena statistički značajna razlika između preživjelih i uginulih. Zaključno, PCT se kao 
i u humanoj medicini vjerojatno može smatrati dobrim markerom za otkrivanje i stupnjevanje SIRS-a samo 
u bakterijskim infekcijama, dok se NT-pCNP pokazao kao dobar prognostički marker ishoda babezioze pasa.
Ključne riječi: babezioza, pas, upalni marker, NT-pCNP, prokalcitonin, ishod________________________________________________________________________________________
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